A. Dehghan, I. Kardys, M. De-maat, A. Uitterlinden, E. Sijbrands et al., Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes, Diabetes, vol.56, issue.3, pp.56-872, 2007.
DOI : 10.2337/db06-0922

D. Freeman, N. J. Caslake, M. Gaw, A. Ford, I. Lowe et al., C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study, Diabetes, vol.51, issue.5, pp.51-1596, 2002.
DOI : 10.2337/diabetes.51.5.1596

J. Krakoff, T. Funahashi, C. Stehouwer, C. Schalkwijk, S. Tanaka et al., Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian, Diabetes Care, vol.26, issue.6, pp.1745-1751, 2003.
DOI : 10.2337/diacare.26.6.1745

D. Laaksonen, L. Niskanen, K. Nyyssonen, K. Punnonen, T. Tuomainen et al., C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men, Diabetologia, vol.47, issue.8, pp.47-1403, 2004.
DOI : 10.1007/s00125-004-1472-x

C. Adler, A. Sandhu, M. Sharp, S. Forouhi, N. Erqou et al., Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis, Diabetologia, vol.52, pp.1040-1047, 2009.

S. Liu, L. Tinker, Y. Song, N. Rifai, D. Bonds et al., A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women, Archives of Internal Medicine, vol.167, issue.15, pp.1676-1685, 2007.
DOI : 10.1001/archinte.167.15.1676

B. Thorand, J. Baumert, H. Kolb, C. Meisinger, L. Chambless et al., Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002, Diabetes Care, vol.30, issue.4, pp.854-860, 1984.
DOI : 10.2337/dc06-1693

S. Wannamethee, N. Sattar, A. Rumley, P. Whincup, L. Lennon et al., Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men. Diabetes Care, pp.31-995, 2008.

J. Danesh, J. Wheeler, G. Hirschfield, S. Eda, G. Eiriksdottir et al., C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease, New England Journal of Medicine, vol.350, issue.14, pp.1387-1397, 2004.
DOI : 10.1056/NEJMoa032804

T. Shah, J. Casas, J. Cooper, I. Tzoulaki, R. Sofat et al., Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts, International Journal of Epidemiology, vol.38, issue.1, pp.217-231, 2009.
DOI : 10.1093/ije/dyn217

G. Hotamisligil, Inflammation and metabolic disorders, Nature, vol.314, issue.7121, pp.860-867, 2006.
DOI : 10.1038/nature05485

J. Cao, A. Arnold, T. Manolio, J. Polak, B. Psaty et al., Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study, Circulation, vol.116, issue.1, pp.32-38, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.645606

M. Bochud, On the use of Mendelian randomization to infer causality in observational epidemiology, European Heart Journal, vol.29, issue.20, pp.2456-2457, 2008.
DOI : 10.1093/eurheartj/ehn428

E. Brunner, M. Kivimaki, D. Witte, D. Lawlor, S. Davey et al., Inflammation, Insulin Resistance, and Diabetes???Mendelian Randomization Using CRP Haplotypes Points Upstream, PLoS Medicine, vol.53, issue.8, p.155, 2008.
DOI : 10.1371/journal.pmed.0050155.st002

L. Palmer, A. Hattersley, S. Ebrahim, G. Lowe, A. Rumley et al., C-reactive protein and its role in metabolic syndrome: mendelian randomisation study, Lancet, vol.366, pp.1954-1959, 2005.

J. Wolford, J. Gruber, V. Ossowski, B. Vozarova, A. Tataranni et al., A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians, Molecular Genetics and Metabolism, vol.78, issue.2, pp.78-136, 2003.
DOI : 10.1016/S1096-7192(02)00230-5

P. Elliott, J. Chambers, W. Zhang, R. Clarke, J. Hopewell et al., Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease, JAMA, vol.302, issue.1, pp.37-48, 2009.
DOI : 10.1001/jama.2009.954

M. Kivimaki, D. Lawlor, G. Smith, M. Kumari, A. Donald et al., Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study PLoS ONE, p.3013, 2008.

D. Lawlor, R. Harbord, N. Timpson, G. Lowe, A. Rumley et al., The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4, PLoS ONE, vol.637, issue.3, pp.610-628, 2008.

J. Zacho, A. Tybjaerg-hansen, J. Jensen, P. Grande, H. Sillesen et al., Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease, New England Journal of Medicine, vol.359, issue.18, pp.1897-1908, 2008.
DOI : 10.1056/NEJMoa0707402

M. Marmot and E. Brunner, Cohort Profile: The Whitehall II study, International Journal of Epidemiology, vol.34, issue.2, pp.251-256, 2005.
DOI : 10.1093/ije/dyh372

K. Alberti and P. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation, Diabetic Medicine, vol.15, issue.7, pp.15-539, 1998.
DOI : 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

S. Stringhini, S. Sabia, M. Shipley, E. Brunner, H. Nabi et al., Association of Socioeconomic Position With Health Behaviors and Mortality, JAMA, vol.303, issue.12, pp.1159-1166, 2010.
DOI : 10.1001/jama.2010.297

URL : https://hal.archives-ouvertes.fr/inserm-00468691

J. Willett, J. Herder, C. Brunner, E. Rathmann, W. Strassburger et al., Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist (IL-1Ra) precede the onset of type 2 diabetes (Whitehall II Study) Diabetes Care, pp.421-423, 2003.

P. Dandona, Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein, Mayo Clinic Proceedings, vol.83, issue.3, pp.333-342, 2008.
DOI : 10.4065/83.3.333

T. Fung, M. Mccullough, P. Newby, J. Manson, J. Meigs et al., Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction, American Journal of Clinical Nutrition, vol.82, pp.163-173, 2005.

C. Kasapis and P. Thompson, The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers, Journal of the American College of Cardiology, vol.45, issue.10, pp.1563-1569, 2005.
DOI : 10.1016/j.jacc.2004.12.077

E. Selvin, N. Paynter, and T. Erlinger, The Effect of Weight Loss on C-Reactive Protein, Archives of Internal Medicine, vol.167, issue.1, pp.31-39, 2007.
DOI : 10.1001/archinte.167.1.31